SCISPARC LTD (SPRC)
IL0010951403 - Common Stock
SCISPARC LTD
NASDAQ:SPRC (11/21/2024, 8:00:02 PM)
Premarket: 0.2593 -0.03 (-10.28%)0.289
+0.05 (+21.38%)
Company Profile
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Company Info
SCISPARC LTD
20 Raul Wallenberg Street, Tower A
TEL AVIV-YAFO
P: 97236103100
Employees: 3
Website: https://scisparc.com/
SPRC News
13 hours ago - ChartmillDiscover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.
2 months ago - SciSparc LtdSciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment2 months ago - SciSparc LtdSciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome TreatmentFDA confirms that SciSparc’s study may proceed only a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ...
2 months ago - SciSparc LtdSciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX2 months ago - SciSparc LtdSciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareXThe intended selling valuation represents an increase of 47% from the valuation at the time of SciSparc’s initial investment in MitoCareX Bio TEL AVIV,...
2 months ago - SciSparc LtdSciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome TreatmentSPRC Twits
Here you can normally see the latest stock twits on SPRC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
